These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20812931)

  • 21. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
    Probst V; Allouis M; Sacher F; Pattier S; Babuty D; Mabo P; Mansourati J; Victor J; Nguyen JM; Schott JJ; Boisseau P; Escande D; Le Marec H
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):270-5. PubMed ID: 16643399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac sodium channelopathy from bench to bedside].
    Zhang YM; Zhou N
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
    [No Abstract]   [Full Text] [Related]  

  • 24. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome].
    Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational screening of SCN5A linked disorders in Polish patients and their family members.
    Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T
    J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brugada syndrome with marked conduction disease: dual implications of a SCN5A mutation.
    Vorobiof G; Kroening D; Hall B; Brugada R; Huang D
    Pacing Clin Electrophysiol; 2008 May; 31(5):630-4. PubMed ID: 18439184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
    Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
    Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel.
    Surber R; Hensellek S; Prochnau D; Werner GS; Benndorf K; Figulla HR; Zimmer T
    Cardiovasc Res; 2008 Mar; 77(4):740-8. PubMed ID: 18065446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
    Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ
    Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization.
    Marangoni S; Di Resta C; Rocchetti M; Barile L; Rizzetto R; Summa A; Severi S; Sommariva E; Pappone C; Ferrari M; Benedetti S; Zaza A
    Cardiovasc Res; 2011 Sep; 91(4):606-16. PubMed ID: 21705349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL
    Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular tests for (early) recognition of heart disease - genetic studies in lethal inherited cardiac arrhythmias].
    Keller DI
    Ther Umsch; 2010 Jul; 67(7):341-8. PubMed ID: 20577962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited cardiac diseases caused by mutations in the Nav1.5 sodium channel.
    Tfelt-Hansen J; Winkel BG; Grunnet M; Jespersen T
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):107-15. PubMed ID: 19845816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
    Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of Brugada Syndrome.
    Vohra J
    Heart Lung Circ; 2011 Dec; 20(12):751-6. PubMed ID: 21943787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel sodium channel SCN5A mutations in Brugada syndrome patients from Greece.
    Kotta CM; Anastasakis A; Gatzoulis K; Manolis AS; Stefanadis C
    Int J Cardiol; 2010 Nov; 145(1):45-8. PubMed ID: 19406494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation.
    Makiyama T; Akao M; Shizuta S; Doi T; Nishiyama K; Oka Y; Ohno S; Nishio Y; Tsuji K; Itoh H; Kimura T; Kita T; Horie M
    J Am Coll Cardiol; 2008 Oct; 52(16):1326-34. PubMed ID: 18929244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
    Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K
    Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.